Co-Authors
This is a "connection" page, showing publications co-authored by Yaoxing Huang and David Ho.
Connection Strength
2.901
-
Design, construction, and characterization of a dual-promoter multigenic DNA vaccine directed against an HIV-1 subtype C/B' recombinant. J Acquir Immune Defic Syndr. 2008 Apr 01; 47(4):403-11.
Score: 0.381
-
Author Correction: Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors. Nat Commun. 2021 May 05; 12(1):2708.
Score: 0.236
-
Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization. Cell Host Microbe. 2021 05 12; 29(5):747-751.e4.
Score: 0.235
-
Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors. Nat Commun. 2021 04 01; 12(1):2016.
Score: 0.234
-
Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7. Nature. 2021 05; 593(7857):130-135.
Score: 0.233
-
SARS-CoV-2 neutralizing antibody responses are more robust in patients with severe disease. Emerg Microbes Infect. 2020 Dec; 9(1):2091-2093.
Score: 0.229
-
Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike. Nature. 2020 08; 584(7821):450-456.
Score: 0.223
-
Engineering multi-specific antibodies against HIV-1. Retrovirology. 2018 08 29; 15(1):60.
Score: 0.196
-
In Vivo Production of Monoclonal Antibodies by Gene Transfer via Electroporation Protects against Lethal Influenza and Ebola Infections. Mol Ther Methods Clin Dev. 2017 Dec 15; 7:74-82.
Score: 0.184
-
Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaques. Proc Natl Acad Sci U S A. 2021 09 21; 118(38).
Score: 0.061
-
Emergence and expansion of SARS-CoV-2 B.1.526 after identification in New York. Nature. 2021 09; 597(7878):703-708.
Score: 0.060
-
Cardiomyocytes recruit monocytes upon SARS-CoV-2 infection by secreting CCL2. Stem Cell Reports. 2021 09 14; 16(9):2274-2288.
Score: 0.060
-
Inhibitors of Coronavirus 3CL Proteases Protect Cells from Protease-Mediated Cytotoxicity. J Virol. 2021 06 24; 95(14):e0237420.
Score: 0.060
-
Structural basis for accommodation of emerging B.1.351 and B.1.1.7 variants by two potent SARS-CoV-2 neutralizing antibodies. Structure. 2021 07 01; 29(7):655-663.e4.
Score: 0.059
-
Nanobodies from camelid mice and llamas neutralize SARS-CoV-2 variants. Nature. 2021 07; 595(7866):278-282.
Score: 0.059
-
An Immuno-Cardiac Model for Macrophage-Mediated Inflammation in COVID-19 Hearts. Circ Res. 2021 06 25; 129(1):33-46.
Score: 0.059
-
Modular basis for potent SARS-CoV-2 neutralization by a prevalent VH1-2-derived antibody class. Cell Rep. 2021 04 06; 35(1):108950.
Score: 0.058
-
Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite. Cell Host Microbe. 2021 05 12; 29(5):819-833.e7.
Score: 0.058
-
In vivo expressed biologics for infectious disease prophylaxis: rapid delivery of DNA-based antiviral antibodies. Emerg Microbes Infect. 2020 Dec; 9(1):1523-1533.
Score: 0.057
-
Identification of SARS-CoV-2 inhibitors using lung and colonic organoids. Nature. 2021 01; 589(7841):270-275.
Score: 0.057
-
A Human Pluripotent Stem Cell-based Platform to Study SARS-CoV-2 Tropism and Model Virus Infection in Human Cells and Organoids. Cell Stem Cell. 2020 07 02; 27(1):125-136.e7.
Score: 0.055
-
DNA Vaccination by Electroporation Amplifies Broadly Cross-Restricted Public TCR Clonotypes Shared with HIV Controllers. J Immunol. 2017 11 15; 199(10):3437-3452.
Score: 0.046